{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:25:02Z","timestamp":1771550702220,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Lacosamide is a third\u2010generation antiepileptic drug used as adjunctive therapy for partial seizures. Since its approval in 2008 very few cases of lacosamide overdose have been described in literature. The aim of our study was to evaluate clinical characteristics of acute lacosamide poisoning.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective observational study was performed including all cases of acute lacosamide poisoning referred to Pavia Poison Control Centre from January 2012 to December 2021. For each patient age, sex, ingested dose, coingestants, clinical manifestations, treatment and outcome were collected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 31 subjects (median age 39\u2009years, [interquartile range: 26.5\u201346.5]; females 22\/31) were included. The median lacosamide ingested dose was 1500\u2009mg [650\u20132800]. In 35.5% of cases lacosamide was the single ingested substance, while in 64.5% coingestants were also present. Coingestants varied from a minimum of 1 to a maximum of 3, with the more common being benzodiazepines and valproic acid. Clinical manifestations were present in 87% patients the most common were: vomiting (29%); seizures (29%), coma (25.8%), drowsiness (25.8%), confusion (12.9%), agitation (12.9%), tachycardia (12.9%), tremors (9.7%), bradycardia (9.7%), headache (6.5%) and hypertension (3.2%). The median lacosamide ingested dose was significantly higher in patients that experienced coma compared to patient who did not (2800 <jats:italic>vs<\/jats:italic>. 800\u2009mg; <jats:italic>P<\/jats:italic>\u00a0=\u2009.0082). Orotracheal intubation was necessary in 32.3% of patients. All patients fully recovered.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Lacosamide acute overdose may lead to a severe clinical picture. Dentral nervous system symptoms predominated, particularly seizures and coma occurred in a high percentage of cases.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.15964","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T04:50:31Z","timestamp":1699851031000},"page":"812-818","source":"Crossref","is-referenced-by-count":5,"title":["Clinical characteristics of acute lacosamide poisoning: Pavia Poison Control Centre experience"],"prefix":"10.1111","volume":"90","author":[{"given":"Lucia","family":"Bernasconi","sequence":"first","affiliation":[{"name":"Pavia Poison Control Centre \u2010 National Toxicology Information Centre \u2010 Clinical and Experimental Lab, Toxicology Unit Istituti Clinici Scientifici Maugeri IRCCS  Pavia Italy"},{"name":"Postgraduate School of Pharmacology and Clinical Toxicology University of Pavia  Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5017-8750","authenticated-orcid":false,"given":"Azzurra","family":"Schicchi","sequence":"additional","affiliation":[{"name":"Pavia Poison Control Centre \u2010 National Toxicology Information Centre \u2010 Clinical and Experimental Lab, Toxicology Unit Istituti Clinici Scientifici Maugeri IRCCS  Pavia Italy"},{"name":"Experimental Medicine PhD Program University of Pavia  Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria M.","family":"Petrolini","sequence":"additional","affiliation":[{"name":"Pavia Poison Control Centre \u2010 National Toxicology Information Centre \u2010 Clinical and Experimental Lab, Toxicology Unit Istituti Clinici Scientifici Maugeri IRCCS  Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Malovini","sequence":"additional","affiliation":[{"name":"Laboratory of Informatics and Systems Engineering for Clinical Research Istituti Clinici Scientifici Maugeri IRCCS  Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Lonati","sequence":"additional","affiliation":[{"name":"Pavia Poison Control Centre \u2010 National Toxicology Information Centre \u2010 Clinical and Experimental Lab, Toxicology Unit Istituti Clinici Scientifici Maugeri IRCCS  Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Fassio","sequence":"additional","affiliation":[{"name":"Department of Public Health, Experimental and Forensic Medicine, Section of Biostatistics and Clinical Epidemiology University of Pavia  Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Buscaglia","sequence":"additional","affiliation":[{"name":"Pavia Poison Control Centre \u2010 National Toxicology Information Centre \u2010 Clinical and Experimental Lab, Toxicology Unit Istituti Clinici Scientifici Maugeri IRCCS  Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Scaravaggi","sequence":"additional","affiliation":[{"name":"Pavia Poison Control Centre \u2010 National Toxicology Information Centre \u2010 Clinical and Experimental Lab, Toxicology Unit Istituti Clinici Scientifici Maugeri IRCCS  Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Crema","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, Section of Pharmacology University of Pavia  Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo A.","family":"Locatelli","sequence":"additional","affiliation":[{"name":"Pavia Poison Control Centre \u2010 National Toxicology Information Centre \u2010 Clinical and Experimental Lab, Toxicology Unit Istituti Clinici Scientifici Maugeri IRCCS  Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528\u20101167.2012.03407.x"},{"key":"e_1_2_9_3_1","unstructured":"PharmaU.Vimpat\u00ae prescribing information.2017."},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528\u20101167.2007.01188.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2006.02.002"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ajp.0000210957.39621.b2"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2010.04.043"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528\u20101167.2011.03212.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2011.02.006"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2015.1040157"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2013.778993"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2010.01.007"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13882"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2019.01.018"},{"issue":"7","key":"e_1_2_9_15_1","first-page":"757","article-title":"Massive lacosamide overdose treated with continuous renal replacement therapy\u20142014 annual meeting of NACCT [Conference abstract]","volume":"52","author":"Boyd M","year":"2014","journal-title":"Clin Toxicol"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxac.2015.02.002"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29547"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181\u2010019\u201000717\u2010y"},{"issue":"7","key":"e_1_2_9_19_1","first-page":"682","article-title":"Safety of lacosamide ingestions\u2014a retrospective poison control center review\u20142014 annual meeting of NACCT [Conference abstract]","volume":"52","author":"Goertemoeller S","year":"2014","journal-title":"Clin Toxicol"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563659009038587"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190019894868"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2021.1945083"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2017.1370096"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2.6.1009"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.5005\/jp\u2010journals\u201010071\u201023301"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12720"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.15964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T08:13:23Z","timestamp":1709108003000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.15964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1111\/bcp.15964"],"URL":"https:\/\/doi.org\/10.1111\/bcp.15964","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]}}}